JPMorgan analyst Anupam Rama lowered the firm’s price target on Solid Biosciences (SLDB) to $12 from $15 and keeps an Overweight rating on the shares. The firm updated models in the Smid-cap biotechnology space.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter